The primary vaccination schedule consists of three doses of 0.5 mL each given intramuscularly within the first six months of life. Three vaccine doses at 6-10-14 weeks of age must be administered at intervals of at least 4 weeks.
Where HBV vaccine is not given at birth, the combined vaccine must be administered beginning as early as 6 weeks of age. Where there is a high endemicity of HBV, the practice to administer HBV vaccine at birth may be continued.
In the case of children born to known HBV carrier mothers, the immuno-prophylactic measures for hepatitis B should not to be modified. This may require separate vaccination with HBV and DTwP vaccines and also include the administration of HBIg at birth.
Method of administration: Uni 5 vial should be shaken well to get a uniform suspension. This pentavalent vaccine is for deep intramuscular injection, preferably in the anterolateral aspect of the thigh. As with all parenteral drug products, aseptic procedures should be followed during the administration of this vaccine.
Parenteral drug products should be inspected visually for extraneous particulate matter and or discoloration prior to administration whenever solution and container permit. If these conditions exist, the vaccine should not be administered.